There is no proof that Remdesivir reduces SARS-Cov2 viral load, but there are confirmed severe adverse effects (renal, liver and cardiac)

Related articles

1. Comprehensive Analysis of Gastrointestinal Injury Induced by Nonsteroidal Anti-Inflammatory Drugs Using Data from the FDA Adverse Event Reporting System Database

   This article has 2 authors:

   1. Motoki Kei
   2. Yoshihiro Uesawa

2. Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients

   This article has 14 authors:

   1. Aitor Gonzaga
   2. Gema Martinez-Navarrete
   3. Loreto Macia
   4. Marga Anton-Bonete
   5. Gladys Cahuana
   6. Juan R. Tejedo
   7. Vanessa Zorrilla-Muñoz
   8. Eduardo Fernandez-Jover
   9. Etelvina Andreu
   10. Cristina Eguizabal
   11. Antonio Pérez-Martínez
   12. Carlos Solano
   13. Luis Manuel Hernández-Blasco
   14. Bernat Soria

3. Cytokine Profiles of the Th1, Th2 and Th17 Response and Clinical Manifestations Associated with SARS-CoV-2 Omicron Subvariants

   This article has 24 authors:

   1. Matheus Amorim Barreto
   2. Amanda Mendes Silva Cruz
   3. Delana Melo Volle
   4. Wanderley Dias das Chagas Júnior
   5. Luana Soares Bargelata
   6. Iran Barros Costa
   7. Juliana Abreu Lima Nunes
   8. Aline Collares Pinheiro de Sousa
   9. Izabel Keller Moreira Lima
   10. Patrícia Yuri Nogami
   11. Iami Raiol Borges
   12. Luany Rafaele da Conceição Cruz
   13. Paula Fabiane da Rocha Nobre
   14. Edvaldo Tavares da Penha Junior
   15. Jones Anderson Monteiro Siqueira
   16. Victória Figueiredo Brito do Carmo
   17. Darleise de Souza Oliveira
   18. Hugo Reis Resque
   19. Marcos Rogério Meneses da Costa
   20. Rita Catarina Medeiros Sousa
   21. Mirleide Cordeiro dos Santos
   22. Maria Izabel de Jesus
   23. Luciana Damascena da Silva
   24. Igor Brasil Costa